Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.94%64.620.0%$960.06m
NVAXNovavax, Inc. 0.05%98.35102.0%$790.87m
AMGNAmgen, Inc. -0.12%251.281.3%$724.36m
REGNRegeneron Pharmaceuticals, Inc. 0.08%640.872.5%$678.20m
GILDGilead Sciences, Inc. -1.06%74.811.0%$620.53m
BIIBBiogen, Inc. -1.37%276.361.6%$614.09m
VRTXVertex Pharmaceuticals, Inc. -0.83%293.461.9%$504.77m
ILMNIllumina, Inc. 0.33%371.103.5%$301.06m
ALXNAlexion Pharmaceuticals, Inc. -1.33%106.562.0%$216.55m
BMRNBioMarin Pharmaceutical, Inc. -2.28%125.794.3%$209.41m
SGENSeattle Genetics, Inc. 2.86%180.566.1%$205.95m
SRNESorrento Therapeutics, Inc. 1.54%7.401.8%$182.86m
IMMUImmunomedics, Inc. 1.83%42.3111.0%$182.75m
SRPTSarepta Therapeutics, Inc. -0.51%169.2813.9%$164.11m
ALNYAlnylam Pharmaceuticals, Inc. -1.83%157.498.5%$161.06m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.